Utility of procalcitonin,Hs-CRP and D-Dimer for diagnosis of pulmonary embolism
10.3969/j.issn.1006-5725.2017.13.039
- VernacularTitle:降钙素原、超敏C反应蛋白与D二聚体对肺动脉栓塞的诊断价值
- Author:
Jianmin HUANG
;
Chunyan LI
;
Yubo SHI
;
Ling AI
- Keywords:
pulmonary embolism;
procalcitonin;
hypersensitive C reactive protein;
D-Dimer
- From:
The Journal of Practical Medicine
2017;33(13):2217-2220
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the value of procalcitonin(PCT),hypersensitive C-reactive protein (Hs-CRP),D-Dimer(DD)in the diagnosis and prognosis judgment of pulmonary embolism(PE). Methods A total of 201 patients were enrolled in the study since the PE diagnosis were made in hospital from JAN. 2013 to DEC. 2016,in which they were divided into high-risk group(n=52),intermediate-risk group(n=88),low-risk group (n = 61),cure-patient group (n = 67) and 36 normal individuals were selected respectively as a blank control group. Results The average of the PCT,Hs-CRP and DD level in the high,intermediate and low-risk group were significant difference comparing with the cure-patient and control group(P<0.05). Conclusions Teh concertration of PCT and Hs-CRP were associated with different risk stratification of PE. Combined with DD , the level of PCT and Hs-CRP can be used to evaluate the risk stratification of PE and help to judge prognosis and guide treatment.
